Figure 1.
MM-206 treatment slows disease progression in a xenograft model of AML. NSG mice were injected iv with 106 MV4-11.ffluc AML cells at day 0. After two weeks, mice began treatment with MM-206 30 mg/kg, or vehicle, ip daily 5 days per week for 2 weeks or 4 weeks (weeks 2 - 4 or 2 - 6). Representative luminescence images from mice one week after completion of two weeks of treatment.
